2 weeks Pfizer Stock Falls 8% in a Month: Should You Buy the Dip? Zacks

Investors with a long-term horizon may consider buying PFE stock at its present attractive valuation.

Biotech · Coronavirus · Pfizer (PFE)

2 weeks Pfizer Stock Falls 8% in a Month: Should You Buy the Dip? Zacks

13 hours Final Trade: GOOG, SAIA, X, PFE YouTube

14 hours Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

14 hours Pfizer climbs 4% on 2025 outlook YouTube

17 hours These States Have the Most Expensive Housing Markets in America 24/7 Wall St.

18 hours Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance

19 hours Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

20 hours Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha

20 hours How to play a potential biotech breakout in 2025 with options CNBC

20 hours Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube

21 hours 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

22 hours Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com

22 hours Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily

22 hours 3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025 Zacks

23 hours Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC

23 hours Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal

23 hours AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

24 hours Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com

24 hours Pfizer forecasts in line 2025 profit as it seeks turnaround Investing.com

24 hours Pfizer Sees 2025 Revenue in Line With Wall Street Views Yahoo Finance

1 day Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion Yahoo Finance

1 day Pfizer projects 2025 earnings to align with expectations Investing.com

1 day Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround CNBC

1 day Pfizer forecasts 2025 profit in line with expectations Investing.com

1 day These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Red Cat, and More Yahoo Finance

1 day Stocks to Watch Tuesday: Pfizer, Alibaba, Super Micro, Affirm Yahoo Finance

2 days What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? Yahoo Finance

2 days ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

2 days ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

2 days Pfizer: Lowest Levels In A Decade Is An Opportunity With A Dividend Yield Exceeding 6.5% Seeking Alpha

2 days Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 Yahoo Finance

3 days Pfizer: Irrational Anti-Vaccine Fear Seeking Alpha

3 days Is Pfizer a Millionaire Maker? Yahoo Finance

5 days KRYS Stock Down on Initial Clinical Updates on KB407 & KB408 Zacks

6 days RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead MarketWatch

6 days The Ultimate Biotech Stock to Buy With $500 Right Now Yahoo Finance

6 days How Pfizer management outplayed activist investor Starboard Yahoo Finance

7 days Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks

7 days Pfizer (PFE) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks

7 days Pfizer: Peer-Leading Dividend And Potential Substantial Shareholder Returns Seeking Alpha

7 days Amazon, Pfizer execs seek common ground with RFK Jr on climate risks to health Investing.com

7 days FDA Grants Fast Track Tag to SNY’s Two COVID & Flu Vaccine Candidates Zacks

7 days Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More Zacks

7 days Investors Slaughter Q32 Bio On A ‘Messy’ Update In Eczema, Alopecia Treatment Investor's Business Daily

7 days Candel Skyrockets 68% On A Potential First-In-20-Years Cancer Drug Investor's Business Daily

7 days Travel ETFs Beat S&P 500 in a Month: Here’s Why? Zacks

7 days NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines Zacks

1 week Pfizer Stock: A Golden Buying Opportunity (Rating Upgrade) Seeking Alpha

1 week Biden says it was ‘stupid’ not to have signed his name on COVID-19 stimulus checks like Trump Business Insider

1 week Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell? Zacks

1 week This Covid-Era Performer Scores Breakaway Gap On Dividend, Earnings Investor's Business Daily

The Stock Market News